Johnson & Johnson Draws Attention Amid Market Volatility

Johnson & Johnson (NYSE:JNJ) is attracting attention as market volatility increases, driven by rising Treasury yields and surging crude prices.

The healthcare company has a long history of steady execution, with a broad and diversified pipeline that reduces dependence on any single therapy or device line.

Last week, the company completed its latest quarterly dividend distribution, continuing a payout record that spans several decades of consecutive annual increases.

Johnson & Johnson's full-year sales and earnings guidance was lifted for a second consecutive stretch, citing broad-based demand across its pharmaceutical portfolio and steady momentum in its medical technology unit.